N-acetyl-L-cysteine inhibits marble-burying behavior in mice

Journal of Pharmacological Sciences

Volumn 119, Issue 1, 2012, Pages 97-101

  Egashira, Nobuaki ^a,b   Shirakawa, Atsunori ^a   Abe, Moe ^a   Niki, Tomiko ^a   Mishima, Kenichi ^a   Iwasaki, Katsunori ^a   Oishi, Ryozo ^b   Fujiwara, Michihiro ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Marble burying behavior; N acetyl L cysteine; Obsessive compulsive disorder

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; FLUVOXAMINE MALEATE; MIRTAZAPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; LOCOMOTION; MALE; MARBLE BURYING BEHAVIOR; MOUSE; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER;

EID: 84861473170     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.11228SC     Document Type: Article

References (15)

1. Rasmussen SA, Eisen JL. The epidemiology and clinical features of obsessive-compulsive disorder. Psychiatr Clin North Am. 1992;15:743-758. (Pubitemid 23032171)
2. Sasson Y, Zohar J, Chopra M, Lustig M, Iancu I, Hendler T. Epidemiology of obsessive-compulsive disorder: a world view. J Clin Psychiatry. 1997;58:7-10. (Pubitemid 27516504)
3. Greist JH, Bandelow B, Hollander E, Marazziti D, Montgomery SA, Nutt DJ, et al.; World Council of Anxiety. WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults. CNS Spectr. 2003;8:7-16. (Pubitemid 38419777)
4. Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS. Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo. Arch Gen Psychiatry. 1989;46:36-44. (Pubitemid 19038406)
5. Koran LM, Gamel NN, Choung HW, Smith EH, Aboujaoude EN. Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation. J Clin Psychiatry. 2005;66:515-520. (Pubitemid 40593581)
6. Arnold PD, Rosenberg DR, Mundo E, Tharmalingam S, Kennedy JL, Richter MA. Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study. Psychopharmacology. 2004;174:530-538. (Pubitemid 39119342)
7. Chakrabarty K, Bhattacharyya S, Christopher R, Khanna S. Glutamatergic dysfunction in OCD. Neuropsychopharmacology. 2005;30:1735-1740. (Pubitemid 43086030)
8. Stewart SE, Jenike EA, Hezel DM, Stack DE, Dodman NH, Shuster L, et al. A single-blinded case-control study of memantine in severe obsessive-compulsive disorder. J Clin Psychopharmacol. 2010;30:34-39.
9. Moran MM, McFarland K, Melendez RI, Kalivas PW, Seamans JK. Cystine/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking. J Neurosci. 2005;25: 6389-6393. (Pubitemid 40962534)
10. Baker DA, McFarland K, Lake RW, Shen H, Tang XC, Toda S, et al. Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci. 2003;6:743-749. (Pubitemid 36792890)
11. Lafleur DL, Pittenger C, Kelmendi B, Gardner T, Wasylink S, Malison RT, et al. N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder. Psychopharmacology (Berl). 2006;184:254-256. (Pubitemid 43084809)
12. 1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice. Jpn J Pharmacol. 1995; 68:65-70.
13. Harasawa T, Ago Y, Itoh S, Baba A, Matsuda T. Role of serotonin type 1A receptors in fluvoxamine-induced inhibition of marbleburying behavior in mice. Behav Pharmacol. 2006;17:637-640. (Pubitemid 44526741)
14. Egashira N, Okuno R, Harada S, Matsushita M, Mishima K, Iwasaki K, et al. Effects of glutamate-related drugs on marble-burying behavior in mice: implications for obsessive-compulsive disorder. Eur J Pharmacol. 2008;586:164-170.
15. LaRowe SD, Mardikian P, Malcolm R, Myrick H, Kalivas P, McFarland K, et al. Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals. Am J Addict. 2006;15:105-110. (Pubitemid 43207196)